Clinical trials sponsored by Sichuan Cancer Hospital and Research Institute

Phase breakdown

Conditions studied

Recruiting trials led by Sichuan Cancer Hospital and Research Institute

• A RCT on the Preventive Effect of HFNC on Postoperative Pulmonary Complications in Patients With Gynecologic Neoplasms
  NCT05526534 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 90 Years · Sex: Female · 1 location
• Neoadjuvant Chemoradiotherapy Compared to Neoadjuvant Chemotherapy for Luminal-Type Locally Advanced Breast Cancer: A Clinical Study
  NCT06697938 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Neoadjuvant/Adjuvant Cadonilimab Plus Chemotherapy in Patients With Resectable PD-L1 Negative NSCLC
  NCT06532591 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Shared Decision Making in Patients With Lung Cancer
  NCT05191485 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study on the Safety and Efficacy of MR-Linac Technique in Patients With Unresectable Locally Advanced Colon Cancer
  NCT06244537 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is Sichuan Cancer Hospital and Research Institute recruiting for?

Sichuan Cancer Hospital and Research Institute is the lead sponsor of 5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.